Quantcast

Latest Pharmaceutical sciences Stories

2014-10-17 08:25:39

BEIJING, Oct. 17, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has received approval from the China Food and Drug Administration (the "CFDA") for commercial manufacturing of human prothrombin complex concentrate ("PCC") at its Shandong Taibang facility. The CFDA inspected Shandong Taibang's new coagulation factor...

2014-10-17 08:24:03

NEW YORK, October 17, 2014 /PRNewswire/ -- BreedIT Corp., (OTCQB: BRDT) through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers (collectively "BreedIT or the "Company"), today announced that its Chief Financial Officer, Oded Gilboa, will be featured in an interview on CEOLIVE.TV, scheduled to air on October 17 2014 at 9:00 am EDT. The...

2014-10-16 23:12:37

On October 10, the FDA announced that the ICU Medical ConMed Stat2 Flow Controller is recalled because it was assembled with the wrong internal component. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) October 16, 2014 AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on Stat2 Flow Controller. The FDA...

2014-10-16 23:06:33

According to new report from BCC Research, the global market for nanoparticles in biotechnology and pharmaceuticals is expected to reach $79.8 billion in 2019, with a compound annual growth rate (CAGR) of 22% for the period 2014 to 2019. (PRWEB) October 16, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY, the global market for nanoparticles in biotechnology and pharmaceuticals is expected to...

2014-10-16 23:05:21

This press release is to inform readers that news of shocking price hikes on generic drugs in US is propelling people to buy from Medicines Mexico Pharmacy. Acapulco, Guerrero (PRWEB) October 16, 2014 According to the Wall Street Journal, a recent analysis found that half of all generic drugs in the US sold through retailers became exceedingly more expensive over the past year. The prices paid by pharmacies for these drugs more than doubled for one out of 11 generic drugs. In some...

2014-10-16 08:32:22

TORONTO, Oct. 16, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that it has completed its non-brokered private placement raising US$2,000,000 through issuance of 20 million common shares at US$0.10 each. The Company is debt free. The proceeds will be used for further development activities at its two subsidiaries BioHaven and Portage Pharma. The common shares issued are subject to...

2014-10-16 08:32:08

New Framework Provides More Predictable, Stable Environment for Payers and Manufacturers TORONTO, Oct. 16, 2014 /CNW/ - Canadians will save an estimated $3.8-billion through an unprecedented three-year agreement reached between Canada's provinces and territories and the generic pharmaceutical industry, Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), said today. "This national framework provides enormous additional savings to Canada's health-care...

2014-10-16 08:31:22

DUBLIN, Oct. 16, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR(®), which is a central nervous system stimulant indicated for the treatment of Attention Deficit...

2014-10-16 08:30:45

Patent estate includes thirteen issued U.S. patents, thirty patents worldwide REDWOOD CITY, Calif., Oct. 16, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today provided an update regarding its growing patent estate which totals 30 issued patents worldwide. These issued patents cover AcelRx's sufentanil...

2014-10-16 08:30:28

ST. LOUIS, Oct. 16, 2014 /PRNewswire/ -- BioReliance(®) (www.bioreliance.com), Sigma-Aldrich Corporation's (NASDAQ: SIAL) biologics and early-development services business under SAFC(®) Commercial (www.sigmaaldrich.com/safc), has introduced select in vitro ADME (absorption, distribution, metabolism and excretion) and toxicology testing services for pharmaceutical, chemical and industrial consumer products to its service offering. The broad set of highly predictive assays use a novel...


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.